Evidence map›Paper›PMID 36143307›Full record

ArticleJournal of personalized medicine2022

Machine Learning Algorithms for Prediction of Survival by Stress Echocardiography in Chronic Coronary Syndromes.

Lauro Cortigiani, Danila Azzolina, Quirino Ciampi, Giulia Lorenzoni, Nicola Gaibazzi, Fausto Rigo, Sonia Gherardi, Francesco Bovenzi, Dario Gregori, Eugenio Picano

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Lauro CortigianiOspedale San Luca, Azienda Usl Toscana Nord Ovest, 55100 Lucca, Italy.ORCID 0000-0002-1804-4939
Danila AzzolinaBiostatistics, Epidemiology and Public Health Unit, Padova University, 35126 Padova, Italy.ORCID 0000-0002-8185-5742
Quirino CiampiCardiology Division, Fatebenefratelli Hospital, 82100 Benevento, Italy.ORCID 0000-0003-4775-8380
Giulia LorenzoniBiostatistics, Epidemiology and Public Health Unit, Padova University, 35126 Padova, Italy.ORCID 0000-0003-1771-4686
Nicola GaibazziDepartment of Cardiology, Parma University Hospital, 43125 Parma, Italy.
Fausto RigoCardiology Division, Villa Salus Hospital, Mestre, 30174 Venezia, Italy.
Sonia GherardiCardiology Division, Cesena Hospital, 47521 Cesena, Italy.
Francesco BovenziOspedale San Luca, Azienda Usl Toscana Nord Ovest, 55100 Lucca, Italy.
Dario GregoriBiostatistics, Epidemiology and Public Health Unit, Padova University, 35126 Padova, Italy.ORCID 0000-0001-7906-0580
Eugenio PicanoCNR, Institute of Clinical Physiology, Biomedicine Department, 56100 Pisa, Italy.
University of Padua · ITAzienda Usl Toscana Centro · ITAzienda-Unita' Sanitaria Locale Di Cesena · ITCluster in Biomedicine · ITFatebenefratelli Hospital · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stress echocardiography (SE) is based on regional wall motion abnormalities and coronary flow velocity reserve (CFVR). Their independent prognostic capabilities could be better studied with a machine learning (ML) approach. The study aims to assess the SE outcome data by conducting an analysis with an ML approach. We included 6881 prospectively recruited and retrospectively analyzed patients with suspected (n = 4279) or known (n = 2602) coronary artery disease submitted to clinically driven dipyridamole SE. The outcome measure was all-cause death. A random forest survival model was implemented to model the survival function according to the patient’s characteristics; 1002 patients recruited by a single, independent center formed the external validation cohort. During a median follow-up of 3.4 years (IQR 1.6−7.5), 814 (12%) patients died. The mortality risk was higher for patients aged >60 years, with a resting ejection fraction < 60%, resting WMSI, positive stress-rest WMSI scores, and CFVR < 3.The C-index performance was 0.79 in the internal and 0.81 in the external validation data set. Survival functions for individual patients were easily obtained with an open access web app. An ML approach can be fruitfully applied to outcome data obtained with SE. Survival showed a constantly increasing relationship with a CFVR < 3.0 and stress-rest wall motion score index > Since processing is largely automated, this approach can be easily scaled to larger and more comprehensive data sets to further refine stratification, guide therapy and be ultimately adopted as an open-source online decision tool.

Indexed as

flow velocity reservemachine learningrandom foreststress echocardiographysurvival

Identifiers

PMID36143307
PMCPMC9504503
OpenAlexW4296353943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.